Data / Form D filings / BioNADrx Holdings, Inc.
BioNADrx Holdings, Inc.: Form D filing
BioNADrx Holdings, Inc., a biotechnology company in Johnson City, TN, filed a Form D with the SEC in 2024. The latest, on January 30, 2024, reports $125,000 sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 207 N. BOONE STREET, SUITE 15, Johnson City, TN, 37604
- Phone
- (216) 470-3047
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2009791
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | New notice | $10,000,000 | $125,000 | $9,875,000 | 1 | Jan 30, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Phillip Mansour | Director | |
| Filip Pinter | Executive Officer, Director | |
| Wendy Kormac | Executive Officer, Director |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of Jan 29, 2024 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioNADrx Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.